Related Experiment Videos
Antibody activity before and after pneumococcal vaccination of otitis-prone and non-otitis-prone children
Insights
Children with recurrent acute otitis media (rAOM) show a poor vaccine response and an inability to mobilize antibodies against pneumococcal bacteria, unlike healthy children.
Area of Science:
- Immunology
- Pediatrics
- Microbiology
Background:
- Recurrent acute otitis media (rAOM) is a common childhood condition.
- Pneumococcal bacteria are a frequent cause of AOM.
- Immune response to pneumococcal vaccines is crucial for prevention.
Purpose of the Study:
- To compare antibody activity against specific pneumococcal serotypes before and after vaccination in children with and without rAOM.
- To investigate potential differences in immune response between these groups.
Main Methods:
- Measurement of IgM, IgG, and IgA antibody activity against pneumococcal types 3, 6A, and 19F.
- Study population included children with rAOM and healthy controls.
- Vaccination with Pneumovax was administered prior to post-vaccination antibody assessment.
Main Results:
- Vaccination elicited only occasional significant increases in antibody activity in all groups.
- No significant difference in vaccine response was observed between rAOM and healthy children.
- Children with rAOM exhibited lower antibody activity against pneumococcus type 6A compared to healthy children, both before and after vaccination.
Conclusions:
- The pneumococcal vaccine response is generally poor in children, regardless of rAOM history.
- Children with rAOM demonstrate an impaired ability to mobilize antibodies against certain pneumococcal types, suggesting a distinct immune deficiency.
- These findings highlight potential gaps in vaccine efficacy and immune function in children susceptible to recurrent ear infections.
Abstract:
The antibody activity of the IgM class and subclasses of IgG and IgA against pneumococcal bacteria of types 3, 6A and 19F was studied before and after administration of a pneumococcal vaccine (Pneumovax) in a group of children with recurrent acute otitis media (rAOM) and in groups of non-otitis-prone children. Only occasionally was there a significant rise in antibody activity after vaccination in any of the groups. There was no difference in the response to vaccination between rAOM children and healthy children. However, rAOM children exhibited lower antibody activities in most Ig subclasses against pneumococcus type 6A--a common causative agent in AOM--before as well as after vaccination compared with the healthy children. The results indicate that the response to vaccination is equally poor in all children, irrespective of whether they have a history of frequent attacks of acute otitis media, but, in contrast to healthy children, the rAOM children seem to have an inability to mobilize antibodies in response to infections with some pneumococcal types.